Sällberg et al., 1991 - Google Patents
IgG subclasses in circulating immune complexes with hepatitis B e antigen in chronic hepatitis B.Sällberg et al., 1991
View PDF- Document ID
- 3461099035165743680
- Author
- Sällberg M
- Norder H
- Lindh G
- Magnius L
- Publication year
- Publication venue
- Clinical and experimental immunology
External Links
Snippet
IgG subclasses of antibodies to hepatitis B e antigen (anti-HBe) complexed to HBeAg were determined in 126 HBsAg-positive sera. In the assay HBeAg complexes were bound to microtitre plates by monoclonal anti-HBe and indicated by biotinylated monoclonals to each …
- 208000002672 Hepatitis B 0 title abstract description 26
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
- G01N33/5761—Hepatitis B
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse Transcribing DNA Viruses
- C12N2730/00011—Reverse Transcribing DNA Viruses
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rizzetto et al. | Transmission of the hepatitis B virus-associated delta antigen to chimpanzees | |
| Budkowska et al. | Hepatitis B virus pre-S gene-encoded antigenic specificity and anti-pre-S antibody: relationship between anti-pre-S response and recovery | |
| Purcell et al. | Radioimmunoassay for the detection of the core of the Dane particle and antibody to it | |
| Neurath et al. | Radioimmunoassay for albumin-binding sites associated with HBsAg: correlation of results with the presence of e-antigen in serum | |
| Norkrans | Clinical, epidemiological and prognostic aspects of hepatitis A, B and “non-A, non-B” | |
| Weber et al. | Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg | |
| Madalinski et al. | Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus. | |
| US4870026A (en) | Non-A, non-B. hepatitis, virus, methods of identification purification, characterization, diagnosis and immunization | |
| Kryger et al. | Enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody to hepatitis B core antigen | |
| Wong et al. | Natural and experimental infection of woodchucks with woodchuck hepatitis virus, as measured by new, specific assays for woodchuck surface antigen and antibody | |
| Yoshizawa et al. | Diagnosis of type A hepatitis by fecal IgA antibody against hepatitis A antigen | |
| Takahashi et al. | Shift from free “small” hepatitis B e antigen to IgG-bound “large” form in the circulation of human beings and a chimpanzee acutely infected with hepatitis B virus | |
| Crivelli et al. | Enzyme-linked immunosorbent assay for detection of antibody to the hepatitis B surface antigen-associated delta antigen | |
| Sällberg et al. | IgG subclasses in circulating immune complexes with hepatitis B e antigen in chronic hepatitis B. | |
| Möller et al. | HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation | |
| Brown et al. | Chronic liver disease: the detection and characterization of circulating immune complexes. | |
| Sällberg et al. | Comparison of class and subclass distribution of antibodies to the hepatitis B core and B e antigens in chronic hepatitis B | |
| Feitelson et al. | X antigen/antibody markers in hepadnavirus infections: Antibodies to the X gene product (s) | |
| Castillo et al. | Detection of HBeAg/anti‐HBe immune complexes in the reactivation of hepatitis B virus replication among anti‐HBe chronic carriers | |
| Prince et al. | A final report on safety and immunogenicity of a bivalent aqueous subunit HBV vaccine | |
| Palla et al. | Complexes of hepatitis B surface antigen and immunoglobulin M in the sera of patients with hepatitis B virus infection | |
| Hess et al. | The demonstration of subtype (D or Y)-specific determinants on the surface of the presumed hepatitis B virus | |
| Vento et al. | Cellular immunity to nucleocapsid and pre-S determinants in asymptomatic carriers of hepatitis B virus. | |
| Chen et al. | Subclasses of antibodies to hepatitis B core antigen in chronic HBV infection: changes during treatment with alpha interferons and predictors of response. | |
| Tassopoulos et al. | Significance of IgM antibody to hepatitis B core antigen in a Greek population with chronic hepatitis B virus infection |